SVANQEL Trademark

Trademark Overview


On Saturday, March 24, 2018, a trademark application was filed for SVANQEL with the United States Patent and Trademark Office. The USPTO has given the SVANQEL trademark a serial number of 79233966. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Tuesday, January 4, 2022. This trademark is owned by NOVARTIS AG. The SVANQEL trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
svanqel

General Information


Serial Number79233966
Word MarkSVANQEL
Filing DateSaturday, March 24, 2018
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateTuesday, January 4, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, January 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Sunday, September 25, 2022NOTIFICATION PROCESSED BY IB
Monday, May 30, 2022NOTIFICATION PROCESSED BY IB
Friday, May 6, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, May 5, 2022DEATH OF INTERNATIONAL REGISTRATION
Thursday, May 5, 2022CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Wednesday, May 4, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 4, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 4, 2022NOTICE OF PUBLICATION
Wednesday, April 20, 2022ATTORNEY REVIEW COMPLETED
Monday, April 18, 2022ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Monday, March 7, 2022REG. CANCELLED - RESTORED TO PENDENCY
Monday, February 28, 2022ASSIGNED TO PETITION STAFF
Wednesday, February 23, 2022REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
Friday, December 28, 2018NOTIFICATION PROCESSED BY IB
Thursday, December 20, 2018CORRECTION TRANSACTION RECEIVED FROM IB
Sunday, December 2, 2018FINAL DISPOSITION NOTICE SENT TO IB
Sunday, December 2, 2018FINAL DISPOSITION PROCESSED
Thursday, November 15, 2018GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, October 16, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, July 31, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2018NOTICE OF PUBLICATION
Wednesday, June 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 26, 2018ASSIGNED TO EXAMINER
Saturday, June 16, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, June 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 11, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, June 7, 2018SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB